Found: 10
Select item for more details and to access through your institution.
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 10, p. 1800, doi. 10.1007/s10147-020-01720-y
- By:
- Publication type:
- Article
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1596, doi. 10.3390/jcm12041596
- By:
- Publication type:
- Article
A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 12, p. 2223, doi. 10.1002/ijc.35116
- By:
- Publication type:
- Article
Safety of Cold Polypectomy for Colorectal Polyps in Patients on Antithrombotic Medication.
- Published in:
- Digestion, 2018, v. 97, n. 1, p. 76, doi. 10.1159/000484219
- By:
- Publication type:
- Article
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y
- By:
- Publication type:
- Article
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y
- By:
- Publication type:
- Article
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603.
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. e642, doi. 10.1093/oncolo/oyac086
- By:
- Publication type:
- Article
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.939425
- By:
- Publication type:
- Article